查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1556576

介入性腫瘤消融市場報告：2030 年趨勢、預測與競爭分析

Interventional Oncology Ablation Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

介入性腫瘤消融趨勢與預測

預計到 2030 年，全球介入性腫瘤消融市場預計將達到 9.079 億美元，2024 年至 2030 年複合年成長率為 8.2%。該市場的主要驅動力是癌症盛行率的上升和消融意識的提高。全球介入性腫瘤消融市場未來性，醫院和診所市場以及門診手術中心市場充滿機會。

按細分市場分類的介入性腫瘤消融趨勢

本研究按技術、適應症、最終用途和地區對全球介入性腫瘤消融進行預測。

介入性腫瘤消融市場洞察

Lucintel 預測，在預測期內，肺癌仍將是最大的細分市場。

在預測期內，醫院和診所將繼續成為該市場的重要組成部分。

在預測期內，北美仍然是最大的地區。

常問問題

Q1.市場規模為：

A1. 至2030年，全球介入性腫瘤消融市場預計將達到9.079億美元。

Q2.市場成長預測是多少：

A2.預計2024年至2030年全球介入性腫瘤消融市場將以8.2%的複合年成長率成長。

Q3.影響市場成長的主要促進因素是：

A3. 該市場的主要驅動力是癌症盛行率的上升和消融意識的提高。

Q4.市場的主要細分市場是：

A4. 介入性腫瘤消融市場前景廣闊，醫院/診所市場和門診手術中心市場充滿機會。

Q5.市場的主要企業是：

A5.介入性腫瘤消融的主要企業有：

  • Boston Scientific Corporation
  • Johnson & Johnson
  • Medtronic
  • Varian Medical Systems
  • EDAP TMS
  • AngioDynamics
  • CASCINATION
  • Merit Medical Systems
  • STARmed
  • Biomedical

Q6.未來最大的細分市場是什麼？

A6.Lucintel 預計肺癌在預測期內仍將是其最大的細分市場。

Q7. 未來五年預計哪些地區的市場成長最大？

A7. 在預測期內，北美仍將是最大的地區。

Q8. 可以客製化報告嗎？

A8. 是的，Lucintel 提供 10% 的客製化服務，無需額外付費。

目錄

第1章執行摘要

第2章全球介入性腫瘤消融市場：市場動態

  • 簡介、背景、分類
  • 供應鏈
  • 產業促進因素與挑戰

第3章 2018-2030年市場趨勢及預測分析

  • 宏觀經濟趨勢（2018-2023）與預測（2024-2030）
  • 全球介入性腫瘤消融市場趨勢（2018-2023）與預測（2024-2030）
  • 按技術分類的全球介入性腫瘤消融市場
    • 射頻消融術
    • 微波消融
    • 冷凍療法
    • 不可逆電穿孔消融
  • 按適應症分類的全球介入性腫瘤消融市場
    • 肝癌
    • 腎癌
    • 肺癌
    • 其他
  • 按最終用途分類的全球介入性腫瘤消融市場
    • 醫院/診所
    • 門診手術中心
    • 其他

第4章 2018-2030年區域市場趨勢及預測分析

  • 全球介入性腫瘤消融市場區域分佈
  • 北美介入性腫瘤消融市場
  • 歐洲介入性腫瘤消融市場
  • 亞太介入腫瘤消融市場
  • 其他區域介入腫瘤消融市場

第5章 競爭分析

  • 產品系列分析
  • 營運整合
  • 波特五力分析

第6章 成長機會與策略分析

  • 成長機會分析
    • 全球介入性腫瘤消融市場技術成長機會
    • 全球介入性腫瘤消融市場成長機會（按適應症）
    • 全球介入性腫瘤消融市場成長機會（依最終用途）
    • 全球介入性腫瘤消融市場按地區成長機會
  • 全球介入性腫瘤消融市場的新趨勢
  • 戰略分析
    • 新產品開發
    • 全球介入性腫瘤消融市場產能擴張
    • 全球介入性腫瘤消融市場的併購與合資
    • 認證和許可

第7章主要企業概況

  • Boston Scientific Corporation
  • Johnson & Johnson
  • Medtronic
  • Varian Medical Systems
  • EDAP TMS
  • AngioDynamics
  • CASCINATION
  • Merit Medical Systems
  • STARmed
  • Biomedical
簡介目錄

Interventional Oncology Ablation Trends and Forecast

The future of the global interventional oncology ablation market looks promising with opportunities in the hospital & clinic and ambulatory surgical center markets. The global interventional oncology ablation market is expected to reach an estimated $907.9 million by 2030 with a CAGR of 8.2% from 2024 to 2030. The major drivers for this market are rising prevalence of cancer and growing awareness of ablation.

A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.

Interventional Oncology Ablation by Segment

The study includes a forecast for the global interventional oncology ablation by technology, indication, end use, and region.

Interventional Oncology Ablation Market by Technology [Shipment Analysis by Value from 2018 to 2030]:

  • Radiofrequency Ablation
  • Microwave Ablation
  • Cryoablation
  • Irreversible Electroporation Ablation

Interventional Oncology Ablation Market by Indication [Shipment Analysis by Value from 2018 to 2030]:

  • Liver Cancer
  • Kidney Cancer
  • Lung Cancer
  • Others

Interventional Oncology Ablation Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Hospitals & Clinics
  • Ambulatory Surgical Centers
  • Others

Interventional Oncology Ablation Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Interventional Oncology Ablation Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies interventional oncology ablation companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the interventional oncology ablation companies profiled in this report include-

  • Boston Scientific Corporation
  • Johnson & Johnson
  • Medtronic
  • Varian Medical Systems
  • EDAP TMS
  • AngioDynamics
  • CASCINATION
  • Merit Medical Systems
  • STARmed
  • Biomedical

Interventional Oncology Ablation Market Insights

Lucintel forecasts that lung will remain the largest segment over the forecast period.

Within this market, hospital & clinic will remain larger segment over the forecast period.

North America will remain the largest region over the forecast period.

Features of the Global Interventional Oncology Ablation Market

Market Size Estimates: Interventional oncology ablation market size estimation in terms of value ($M).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Interventional oncology ablation market size by technology, indication, end use, and region in terms of value ($M).

Regional Analysis: Interventional oncology ablation market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different technologies, indications, end uses, and regions for the interventional oncology ablation market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the interventional oncology ablation market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the interventional oncology ablation market size?

Answer: The global interventional oncology ablation market is expected to reach an estimated $907.9 million by 2030.

Q2. What is the growth forecast for interventional oncology ablation market?

Answer: The global interventional oncology ablation market is expected to grow with a CAGR of 8.2% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the interventional oncology ablation market?

Answer: The major drivers for this market are rising prevalence of cancer and growing awareness of ablation.

Q4. What are the major segments for interventional oncology ablation market?

Answer: The future of the interventional oncology ablation market looks promising with opportunities in the hospital & clinic and ambulatory surgical center markets.

Q5. Who are the key interventional oncology ablation market companies?

Answer: Some of the key interventional oncology ablation companies are as follows:

  • Boston Scientific Corporation
  • Johnson & Johnson
  • Medtronic
  • Varian Medical Systems
  • EDAP TMS
  • AngioDynamics
  • CASCINATION
  • Merit Medical Systems
  • STARmed
  • Biomedical

Q6. Which interventional oncology ablation market segment will be the largest in future?

Answer: Lucintel forecasts that lung will remain the largest segment over the forecast period.

Q7. In interventional oncology ablation market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the interventional oncology ablation market by technology (radiofrequency ablation, microwave ablation, cryoablation, and irreversible electroporation ablation), indication (liver cancer, kidney cancer, lung cancer, and others), end use (hospitals & clinics, ambulatory surgical centers, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Interventional Oncology Ablation Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Interventional Oncology Ablation Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Interventional Oncology Ablation Market by Technology
    • 3.3.1: Radiofrequency Ablation
    • 3.3.2: Microwave Ablation
    • 3.3.3: Cryoablation
    • 3.3.4: Irreversible Electroporation Ablation
  • 3.4: Global Interventional Oncology Ablation Market by Indication
    • 3.4.1: Liver Cancer
    • 3.4.2: Kidney Cancer
    • 3.4.3: Lung Cancer
    • 3.4.4: Others
  • 3.5: Global Interventional Oncology Ablation Market by End Use
    • 3.5.1: Hospitals & Clinics
    • 3.5.2: Ambulatory Surgical Centers
    • 3.5.3: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Interventional Oncology Ablation Market by Region
  • 4.2: North American Interventional Oncology Ablation Market
    • 4.2.1: North American Interventional Oncology Ablation Market by Indication: Liver Cancer, Kidney Cancer, Lung Cancer, and Others
    • 4.2.2: North American Interventional Oncology Ablation Market by End Use: Hospitals & Clinics, Ambulatory Surgical Centers, and Others
  • 4.3: European Interventional Oncology Ablation Market
    • 4.3.1: European Interventional Oncology Ablation Market by Indication: Liver Cancer, Kidney Cancer, Lung Cancer, and Others
    • 4.3.2: European Interventional Oncology Ablation Market by End Use: Hospitals & Clinics, Ambulatory Surgical Centers, and Others
  • 4.4: APAC Interventional Oncology Ablation Market
    • 4.4.1: APAC Interventional Oncology Ablation Market by Indication: Liver Cancer, Kidney Cancer, Lung Cancer, and Others
    • 4.4.2: APAC Interventional Oncology Ablation Market by End Use: Hospitals & Clinics, Ambulatory Surgical Centers, and Others
  • 4.5: ROW Interventional Oncology Ablation Market
    • 4.5.1: ROW Interventional Oncology Ablation Market by Indication: Liver Cancer, Kidney Cancer, Lung Cancer, and Others
    • 4.5.2: ROW Interventional Oncology Ablation Market by End Use: Hospitals & Clinics, Ambulatory Surgical Centers, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Interventional Oncology Ablation Market by Technology
    • 6.1.2: Growth Opportunities for the Global Interventional Oncology Ablation Market by Indication
    • 6.1.3: Growth Opportunities for the Global Interventional Oncology Ablation Market by End Use
    • 6.1.4: Growth Opportunities for the Global Interventional Oncology Ablation Market by Region
  • 6.2: Emerging Trends in the Global Interventional Oncology Ablation Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Interventional Oncology Ablation Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Interventional Oncology Ablation Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Boston Scientific Corporation
  • 7.2: Johnson & Johnson
  • 7.3: Medtronic
  • 7.4: Varian Medical Systems
  • 7.5: EDAP TMS
  • 7.6: AngioDynamics
  • 7.7: CASCINATION
  • 7.8: Merit Medical Systems
  • 7.9: STARmed
  • 7.10: Biomedical